Arvinas (ARVN) Non Operating Income (2017 - 2026)
Arvinas (ARVN) recorded Non Operating Income of $5.4 million in Q3 2026, down 40.0% from $9 million a year earlier and down 1.8% from the prior quarter.
Arvinas (ARVN) Non Operating Income (2017 - 2026) Analysis & Trends
On a TTM basis, Arvinas' Non Operating Income came in at $24.6 million as of Sep 30, 2026, down 43.3% year-over-year; for FY2025, it came in at $38 million, down 26.8% from FY2024.
- Annual Non Operating Income has a five-year compound annual growth rate of 46.7% (FY2020 to FY2025).
- Across earlier years, Non Operating Income came in at $51.9 million in FY2024 (+38.0%), $37.6 million in FY2023 (+208.2%), $12.2 million in FY2022 (+183.7%) and $4.3 million in FY2021 (-23.2%).
- The Q3 2026 figure is the lowest quarterly Non Operating Income since Q3 2022.
- On a year-over-year basis, Non Operating Income has declined for seven consecutive quarters, with an average decline of 29.2% over the last eight quarters.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 540.0% in Q3 2022, against a decline of 46.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.5 million (Q2 2026), $6.3 million (Q1 2026) and $7.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 | 5.40 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.40 Mn |
| Jun 30, 2026 | 5.50 Mn |
| Mar 31, 2026 | 6.30 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.70 Mn |
| Dec 31, 2024 | 12.70 Mn |
| Sep 30, 2024 | 11.70 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 12.10 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.40 Mn |
Arvinas Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();